NASDAQ:BHF

Brighthouse Financial (NASDAQ: BHF) Navigates Q2 2026 Earnings Miss with Strong Net Income Growth

Font: Financial Modeling Prep  • Aug 06, 2026

Market Chart
  • Brighthouse Financial (NASDAQ: BHF) reported Q2 2026 earnings and revenue below analyst consensus estimates.
  • Despite the misses, the company saw a substantial increase in net income, leading to a higher diluted EPS.
  • Key financial health indicators include a trailing P/E ratio of 4.88 and a debt-to-equity ratio of 0.48.

Brighthouse Financial is a major provider of annuities and life insurance products in the United States. Spun off from MetLife, the company operates in the competitive life insurance industry. It focuses on helping clients secure their financial futures through its various insurance and investment offerings.

On August 6th, 2026, Brighthouse Financial reported its second-quarter financial results, which did not meet analyst expectations. The company announced quarterly earnings of $4.45 per share. This figure missed the analyst consensus estimate of $4.86 per share. As highlighted by Zacks, this represents a 10.64% negative surprise against their consensus estimate of $4.98.

The company’s revenue for the quarter also fell short of projections. Brighthouse Financial announced revenue of $2.11 billion, below the consensus estimate of $2.18 billion. This result is a 2.4% decline from the same period last year. It also marks an 8.14% negative surprise compared to the Zacks Consensus Estimate of $2.29 billion.

Despite missing these estimates, Brighthouse Financial reported a significant increase in net income available to shareholders. As announced by Business Wire, this figure was $956 million for the quarter. This is a substantial rise from the $60 million reported in the second quarter of 2025, resulting in a diluted EPS of $16.53.

A look at the company's financial health shows a trailing price-to-earnings (P/E) ratio of 4.88. This metric compares the company's stock price to its earnings per share. Brighthouse Financial also maintains a debt-to-equity ratio of 0.48, which indicates how it pays for its assets using debt versus shareholder equity.

Market Overview
ENSC
Ensysce Biosciences, Inc.
$0.52
44.83%
SURG
SurgePays, Inc.
$0.33
45.48%
CELZ
Creative Medical Technology Holdings, Inc.
$1.15
71.95%
SPCX
Space Exploration Technologies Corp.
$114.92
6.14%
GAUZ
Gauzy Ltd. Ordinary Shares
$0.43
69.53%
ONFO
Onfolio Holdings, Inc.
$0.06
-17.36%
HTZ
Hertz Global Holdings, Inc.
$2.02
29.49%
NVDA
NVIDIA Corporation
$218.99
-0.10%
UWMC
UWM Holdings Corporation
$1.20
-34.78%
SOUN
SoundHound AI, Inc.
$7.08
10.11%